Dual-response CuS@MnO<sub>2</sub> nanoparticles with activatable CT/MR-enhanced <i>in vivo</i> imaging guided photothermal therapy.

RSC Adv · 2019 · PMC9059815 · PMID 35520512

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The tumor volume of the mice treated with the CuS@MnO 2 NPs or CuS@MnO 2 –RGD NPs under 1064 nm laser irradiation were obviously suppressed and appeared to show a decreasing trend, and the curative effect of the CuS@MnO 2 –RGD NPs was slightly better than that of the CuS@MnO 2 NPs owing to the great enrichment of the CuS NPs in the tumors.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.